Review began 05/01/2022 review ended 05/16/2022 published 05/23/2022 © copyright

HIGHLIGHTS

• who: Receptor (PD- and colleagues from the India India India have published the research work: Review began 05/01/2022 Review ended 05/16/2022 Published 05/23/2022 u00a9 Copyright, in the Journal: (JOURNAL) of May/23,/2022
• what: The salient features of our study are that the data on the expression of PD-1 and PD-L1 in NSCLC, especially from India, is very limited.
• future: While previous studies have found a relationship between the tumor type and PD-1 or PD-L1 status these studies have been inconsistent as to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.